NEJM Group

CardioExchange Archive

CardioExchange, an NEJM practice community for medical professionals dedicated to improving cardiac patient care, was active from 2009 to 2015. CardioExchange fostered discussion between clinicians from across the globe.

Posts Tagged ‘dietary sodium’

RSS

January 26th, 2015

Selections from Richard Lehman’s Literature Review: January 26th

Richard Lehman, BM, BCh, MRCGP

This week’s topics include dietary sodium content, mortality, and CVD risk in older adults, the ROX CONTROL HTN study, and more.

Categories: General
Tags: acute myocardial infarction, biolimus-eluting biodegradable-polymer-coated stent, cardiovascular risk, central arteriovenous anastomosis, dietary sodium, Elecsys Troponin T high-sensitive assay, high-sensitivity cardiac troponin, mortality, myocardial infarction, older patients, uncontrolled hypertension, women, zotarolimus-eluting durable-polymer-coated stent


  • Search the Archive

  • Archives by Date

  • RSS NEJM — Recent Cardiology Articles

    • Seeing the Left Main Coronary Artery Clearly — Is IVUS Always Necessary? March 30, 2026
      Treatment of the left main coronary artery with percutaneous coronary intervention (PCI) in the absence of previous surgical revascularization, also referred to as an unprotected left main coronary artery PCI, is one of the riskier tasks that interventional cardiologists are asked to perform. Stent implantation in the left main coronary...
    • Sirolimus-Coated Balloon Angioplasty for Infrainguinal Artery Disease March 30, 2026
      Among patients with infrainguinal artery disease who were undergoing angioplasty, the risk of major adverse limb events at 1 year was lower with sirolimus-coated balloons than with uncoated balloons, and mortality was similar.
    • IVUS — A Zigzag Path to Success March 30, 2026
      The use of intravascular ultrasound (IVUS) imaging for assessment of the coronary arteries has an almost 40-year history. In an editorial comment on an early ex vivo assessment of the accuracy of IVUS in evaluating human coronary arteries, Yock and Linker1 posed three questions that remain relevant today:...
    • Sirolimus-Eluting Technology for the Treatment of Peripheral Artery Disease March 30, 2026
      Patients with advanced peripheral artery disease often undergo either surgical or endovascular revascularization for the treatment of lifestyle-limiting claudication or nonhealing lower-limb wounds. Major limitations of endovascular intervention include the high incidence of restenosis and the need for repeat intervention with standard balloon angioplasty. During the past decade, the use...
    • Discontinuation of Beta-Blocker Therapy after Myocardial Infarction March 30, 2026
      Among patients with a preserved ejection fraction at least 1 year after myocardial infarction, stopping beta-blockers was noninferior to continuing therapy with respect to major clinical outcomes.
  • Tag Cloud

    • ACS AF AHA anticoagulation aortic valve replacement apixaban aspirin atrial fibrillation CABG cardiovascular risk cholesterol clopidogrel dabigatran diabetes diet drug-eluting stents epidemiology ESC exercise FDA FDA approvals Fellowship training guidelines HDL heart failure hypertension ICDs MI myocardial infarction obesity PCI Primary PCI risk factors rivaroxaban statins STEMI stents stroke stroke prevention TAVI TAVR type 2 diabetes venous thromboembolism warfarin women
NEJM Group

Copyright © 2026 Massachusetts Medical Society. All rights reserved.

The content of this site is intended for health care professionals. Copyright | Terms | Privacy Policy |